Latest Commercialisation News

Micro-X Limited has secured $6 million through a share placement to accelerate commercialisation of its innovative medical imaging technologies, with strategic partner Billion Prima increasing its stake to 8.5%. The capital raise supports key clinical trials and product development milestones.

Cleo Diagnostics has raised $5 million to support the U.S. commercial launch of its Pre-Surgical Ovarian Cancer Test and accelerate development of a mass screening test, signaling strong investor confidence in its technology.

Memphasys Limited’s partner International Technical Legacy has placed an early order for 500 Felix™ cartridges ahead of anticipated CE Mark approval, signalling strong clinic demand and validating the company’s direct-selling strategy in the Middle East.

BlinkLab Limited has appointed its Co-Founder and CEO, Dr Henk-Jan Boele, as Managing Director to steer the company through its pivotal FDA 510(k) trial for its autism diagnostic technology. The move coincides with key board changes and signals a strategic shift as BlinkLab prepares for early commercialisation.

Bio-Gene Technology reports promising progress on its US Department of Defense-funded insecticide projects, with early mosquito mortality evidence from its Flavocide wearable device and pending launch of its Qcide indoor spray program.

SportsHero Limited has secured its largest-ever cash receipt of approximately A$530,000 following the successful rollout of its iGV.Com Game Pass in the Philippines, marking a pivotal step in its commercial journey.

Asian Battery Metals PLC reports outstanding metallurgical test results from its Oval Cu-Ni-PGE project in Mongolia, confirming high copper recoveries of up to 95% with a simple flotation process and no penalty elements. Nickel concentrate optimization is underway, supporting the project's development trajectory.

Anatara Lifesciences reports encouraging pre-clinical results for its anti-obesity candidate AOC, demonstrating significant reductions in weight regain and visceral fat in mice. However, a delay in mechanism of action studies pushes full data release to January 2026.

Epiminder Limited has settled a $15.77 million tax liability with the ATO related to historical R&D claims, freeing up $4.23 million from IPO proceeds for working capital.

Emperor Energy appoints Tim Handley as Managing Director to spearhead the Judith Gas Field's next phase, including the critical Judith-2 appraisal well planned for Q3 2026.

DataWorks Group signals a turning point with its strongest quarterly operating cash flow since refocusing on its core RegTech business, driven by key contracts in Australia and Ontario.

Proteomics International has secured a US patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma, marking a critical step toward commercialisation in the world’s largest healthcare market.